Luca Healthcare’s mission is to provide affordable, accessible, and clinically validated digital tools to improve healthcare in China through innovation and best-in-class global partnerships
Luca Healthcare operates at the intersection of healthcare, science, and technology. Simply put, we develop digital tools that diagnose, monitor and treat diseases. Our focus is implementing the most relevant and clinically validated digital tools in clinical trials, healthcare and consumer markets.
Our business model enables us to work effectively with partners worldwide. Our platform and local data infrastructure allow our global partners to work within China’s regulatory framework. Our portfolio-based, go-to-market approach maximizes each partner’s asset value by delivering each asset as a standalone solution and as part of a combination solution to address a wider range of use cases.
Cambridge Cognition and Luca Healthcare Announce a Strategic Partnership and an Exclusive Licensing Agreement to Commercialize Cambridge Cognition's Suite of Cognitive Assessment Tools and Brain Health Products for the China Market
Sperogenix Therapeutics and Luca Healthcare Announce a Strategic Collaboration to Develop Digital Therapeutics for Sperogenix’s Platform of Rare Disease Treatments
Thermo Fisher Scientific (China) and Luca Healthcare Announce a Strategic Collaboration to Explore Developing a Digital Patient Assistant and Digital Medication Adherence Solutions to Support Direct-to-Patient Clinical Trial Services in China
AstraZeneca (China) and Luca Healthcare Announce a Strategic Partnership to Develop Out-of-Hospital Digital Tools for Screening and Management of Respiratory Diseases and to Explore Digital Solutions to Support R&D and Clinical Trials in China
Shanghai Pharmaceuticals and Luca Healthcare Announce a Strategic Collaboration to Provide Home Drug Delivery to Rare Disease Patients on Luca Healthcare's Patient Management Platform
